age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
60.57999
|
female
| 1
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 2,080
| 1,654.6143
| 1,357.58984
| 10
|
white
| 26.699219
| 27
| 0.792969
| 0.667969
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 1
| 77
| 13.699219
| 106
| 22
| 35.5
| null | 3.299805
| 2.899902
| 1.099854
| 131
| null | null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 4
| 1
|
70.10498
|
male
| 0
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
|
>$50k
| 0
| 76,778
| 67,495.8125
| 43,702.6562
| 19.666656
|
white
| 17.097656
| 18
| 0.72998
| 0.646973
| 63
| 0
| 0
|
yes
| null | null |
no dnr
| 15
| 73
| 8.699219
| 118
| 24
| 38.59375
| 285.6875
| null | null | 1
| 143
| 7.479492
| null | null | null | null | 2
| null | 2
| 1,858
| 0
|
58.793
|
male
| 0
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 11
|
$11-$25k
| 0
| 54,473
| 38,711.1562
| 34,905.0938
| 23.333328
|
white
| 28.398438
| 33
| 0.416992
| 0.296997
| 15
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 77
| 35.09375
| 102
| 26
| 38.89844
| 129.0625
| 2.5
| 1.799805
| 0.599976
| 136
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 3.420898
| 51
| 1
|
75.13495
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 8,814
| 6,860.8555
| 6,942.03906
| 18
|
white
| 19.398438
| 19
| 0.820923
| 0.708984
| 1
| 0
| 0
|
no
| 0.95
| 0.7
|
dnr after sadm
| 1
| 85
| null | 107
| 24
| 36.19531
| 204
| null | null | null | 140
| 7.349609
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 13
| 1
|
77.60394
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
under $11k
| 0
| 25,038
| 16,361.9688
| 17,482.7812
| 43.5
|
white
| 20.699219
| 38
| 0.797974
| 0.730957
| 2
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 63
| 10.398438
| 74
| 26
| 37.89844
| 265
| null | 1
| 2.699707
| 138
| 7.379883
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 10
| 1
|
72.75
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 41
| 4,467
| 3,677.4961
| 2,880.95898
| 9.5
|
white
| 17.898438
| 10
| 0.75
| 0.60498
| 1
| 0
| 1
|
no
| 0.6
| 0.5
|
dnr after sadm
| 1
| 82
| 7.399414
| 60
| 24
| 36.79688
| 240
| null | null | 0.5
| 137
| 7.40918
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 447
| 1
|
97.26495
|
female
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 8,296
| 6,480.2188
| 5,072.75
| 13.5
|
white
| 16.796875
| 33
| 0.708984
| 0.549927
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 12
| 113
| 12.5
| 110
| 40
| 36.09375
| 388
| 4.399414
| 0.399963
| 1
| 139
| 7.349609
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 1,038
| 1
|
75.31299
|
male
| 1
| 12
|
Lung Cancer
|
Cancer
| 2
| 8
|
$11-$25k
| 0
| 13,414
| 9,397.8672
| 7,863.01953
| 16
|
white
| 38.59375
| 38
| 0.109985
| 0.004
| 1
| 0
| 0
|
metastatic
| 0.51
| 0.2
|
dnr after sadm
| 1
| 76
| 5
| 122
| 28
| 36.09375
| null | 2.299805
| 0.899902
| 0.599976
| 132
| null | null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 12
| 1
|
60.93399
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$25-$50k
| 0
| 4,130
| 2,908.0137
| 2,926.44922
| 15
|
white
| 19
| 16
| 0.861938
| 0.770996
| 1
| 0
| 0
|
yes
| 0.95
| 0.75
|
dnr after sadm
| 2
| 102
| 6.899414
| 72
| 20
| 36.59375
| 347.5625
| 4
| 0.5
| 0.5
| 125
| 7.399414
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 306
| 1
|
74.30298
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 6,503
| 4,888.7773
| 3,947.50977
| 13
|
white
| 15.898438
| 30
| 0.865967
| 0.777954
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 10
| 102
| 8.798828
| 84
| 28
| 36.39844
| 264
| null | null | 1.199951
| 138
| 7.379883
| null | null | null | null | null | null | 2.767578
| 1,849
| 0
|
86.26398
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 3,748
| 3,288.6504
| 2,415.18945
| 9
|
white
| 17.796875
| 29
| 0.81897
| 0.705933
| 1
| 1
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 8
| 110
| 7.099609
| 65
| 32
| 36.39844
| null | 3.399902
| 0.699951
| 1.199951
| 134
| null | null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,466
| 1
|
63.017
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 26
| 51,051
| null | null | 33
|
white
| 20.398438
| 24
| 0.72998
| 0.646973
| 20
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 11
| 127
| 8.898438
| 102
| 26
| 38.19531
| 200
| 3.199707
| 1.199951
| 0.699951
| 133
| 7.449219
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.61084
| 1,848
| 0
|
78.073
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
| null | 0
| 4,193
| 3,009.7422
| 3,151.2793
| 20
|
white
| 22.097656
| 42
| 0.761963
| 0.621948
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
dnr after sadm
| 1
| 68
| 7.099609
| 122
| 40
| 36.19531
| 234.78125
| 3.449707
| 0.5
| 1
| 140
| 7.369141
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,664
| 1
|
74.00397
|
female
| 0
| 18
|
Colon Cancer
|
Cancer
| 1
| 9
|
under $11k
| 0
| 8,549
| 7,534.168
| 7,275.88672
| 7.666664
|
white
| 8.099609
| 23
| 0.896973
| 0.763916
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 18
| 68
| 10.398438
| 71
| 24
| 37.29688
| null | 4
| 0.599976
| 1.099854
| 138
| null | null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 217
| 1
|
57.51099
|
male
| 1
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 3,293
| 2,865.4961
| 2,124.48828
| 7
|
white
| 21.398438
| 23
| 0.86792
| 0.781982
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 63
| 6.899414
| 57
| 20
| 35.69531
| null | null | null | 1.299805
| 130
| null | null | null | null | 1
| 2
|
<2 mo. follow-up
| 2
| 6
| 1
|
63.06897
|
female
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 13,703
| 10,648.0156
| 8,112.57812
| 7.666664
|
white
| 18.898438
| 20
| 0.87793
| 0.796997
| 1
| 1
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 17
| 63
| null | 53
| 20
| 35.59375
| null | null | null | 1.199951
| 140
| null | null | null | null | null | null | null | 2.957031
| 1,845
| 0
|
71.90698
|
male
| 0
| 23
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 8
| null | 0
| 27,122
| 18,723.4531
| 17,011.8594
| 12
|
white
| 19.699219
| 34
| 0.794922
| 0.670898
| 1
| 1
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 126
| 12
| 104
| 29
| 36.39844
| 220
| 3.799805
| 0.799927
| 1.399902
| 136
| 7.479492
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 27
| 1
|
71.79498
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 13
|
$11-$25k
| 0
| 4,419
| 3,358.459
| 2,894.5
| 17
|
white
| 12.099609
| 34
| 0.907959
| 0.844971
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 103
| 8
| 58
| 28
| 36.89844
| null | 4.799805
| 0.5
| 1.599854
| 145
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,840
| 0
|
74.75397
|
female
| 1
| 48
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 48,359
| 37,019.1875
| 32,157.1562
| 11.75
|
white
| 26
| 25
| 0.62793
| 0.315979
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 37
| 64
| 7.099609
| 62
| 24
| 36.39844
| null | 2.899902
| 4.699219
| 0.899902
| 140
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.674316
| 48
| 1
|
66.86096
|
male
| 0
| 38
|
Coma
|
Coma
| 2
| null | null | 61
| 63,139
| 41,355.1562
| 42,469.25
| 24.5
|
white
| 27.296875
| 40
| 0.28894
| 0.218994
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 38
| 57
| 11.298828
| 116
| 36
| 40
| 276.625
| 2.699707
| 0.799927
| 0.599976
| 133
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,838
| 0
|
61.16898
|
female
| 0
| 56
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 133,465
| 89,469.875
| 94,790.4375
| 30.5
|
white
| 31.898438
| 38
| 0.622925
| 0.438965
| 21
| 1
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 32
| 145
| 11
| 154
| 24
| 39.59375
| 236.65625
| 2.199707
| 0.299988
| 0.599976
| 152
| 7.319336
| null | null | null | null | 5
| null | 5
| 60
| 1
|
80.76398
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
|
$11-$25k
| 0
| 3,553
| 2,823.6777
| 2,881.34961
| 16
|
white
| 16.796875
| 26
| 0.823975
| 0.713989
| 1
| 0
| 0
|
no
| 0.9
| 0.4
|
dnr after sadm
| 2
| 66
| 8.298828
| 118
| 24
| 36.09375
| 270.3125
| 4
| 0.899902
| 1
| 137
| 7.439453
| null | null | null | 0
| null | null | 0.4948
| 1,833
| 0
|
58.14099
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 22,293
| 17,607.4688
| 16,129.4766
| 19.666656
|
white
| 23.5
| 47
| 0.834961
| 0.778931
| 1
| 0
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 2
| 62
| 6.799805
| 132
| 40
| 40
| 252.375
| 3.799805
| 1.299805
| 1
| 140
| 7.519531
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 41
| 1
|
50.74597
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 2,421
| 1,880.4121
| 1,710.12988
| 8
|
white
| 18.199219
| 15
| 0.925903
| 0.875
| 1
| 0
| 0
|
no
| 0.85
| 0.85
|
no dnr
| 4
| 77
| 8.699219
| 98
| 20
| 36.79688
| 183.3125
| null | null | 1
| 142
| 7.439453
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,832
| 0
|
71.28296
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 4,032
| 3,012.9531
| 2,722.98828
| 27
|
white
| 16.097656
| 27
| 0.710938
| 0.429993
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 2
| 65
| null | 79
| 28
| 38
| 182.5
| null | null | null | 140
| 7.429688
| null | null | null | null | 2
|
adl>=4 (>=5 if sur)
| 2
| 139
| 1
|
64.74194
|
female
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
$11-$25k
| 0
| 66,579
| 44,250.1562
| 44,276.0938
| 35.5
|
white
| 35
| 60
| 0.593994
| 0.485962
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 35
| 127
| 10.199219
| 104
| 42
| 39.19531
| 84
| 2.5
| 3.399902
| 2.099609
| 137
| 7.399414
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,830
| 0
|
83.05798
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 3,829
| 3,359.2793
| 2,520.75977
| 5.5
|
white
| 23.597656
| 33
| 0.74292
| 0.594971
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 8
| 101
| 11.398438
| 60
| 24
| 35.69531
| null | null | 0.5
| 2.099609
| 133
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.918457
| 39
| 1
|
62.37399
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| null | null | 9
| 2,110
| 1,810.6055
| 1,562.84961
| 5
|
white
| 21
| 29
| 0.588989
| 0.268982
| 1
| 0
| 0
|
metastatic
| null | null |
dnr before sadm
| -1
| 73
| 15
| 114
| 10
| 35.89844
| null | 3.599609
| 0.299988
| 0.899902
| 127
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.416016
| 7
| 1
|
85.15796
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 5
|
$11-$25k
| 0
| 15,484
| 12,240.1953
| 9,871.42969
| 19
|
white
| 27.398438
| 49
| 0.658936
| 0.560913
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 20
| 73
| 11.699219
| 115
| 32
| 38
| 190
| 3.699707
| 0.899902
| 2.299805
| 136
| 7.459961
| null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 99
| 1
|
74.31097
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 16,942
| 11,618.4844
| 11,960.1094
| 32
|
white
| 29.5
| 51
| 0.631958
| 0.529907
| 3
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 5
| 72
| 12.099609
| 116
| 42
| 38.19531
| 192.5
| 3.599609
| 0.699951
| 2.099609
| 131
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.657227
| 8
| 1
|
60.78299
|
female
| 0
| 14
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 9,817
| 7,615.7344
| 6,641.13672
| 10
|
white
| 25.199219
| 17
| 0.525879
| 0.203979
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 14
| 96
| 11.398438
| 118
| 16
| 37
| 280.9375
| null | null | 0.5
| 130
| 7.469727
| null | null | null | 1
| 3
|
<2 mo. follow-up
| 3
| 52
| 1
|
63.41397
|
female
| 0
| 13
|
Lung Cancer
|
Cancer
| 2
| 8
|
under $11k
| 26
| 10,723
| 7,882.6562
| 6,968.05859
| 17
|
white
| 24.296875
| 45
| 0.409973
| 0.109985
| 1
| 1
| 0
|
metastatic
| 0.6
| 0.1
|
dnr after sadm
| 1
| 112
| 13.898438
| 174
| 28
| 36
| 285.6875
| null | null | 1.299805
| 139
| 7.419922
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 66
| 1
|
58.22897
|
male
| 1
| 6
|
Lung Cancer
|
Cancer
| 2
| null | null | 26
| 3,920
| 3,139.7871
| 2,740.88867
| 14
|
white
| 26.898438
| 17
| 0.350952
| 0.074997
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 75
| 8.599609
| 81
| 28
| 36.39844
| null | 2.599609
| 1.299805
| 0.799927
| 136
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.911621
| 6
| 1
|
61.42398
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 16,383
| 12,483.0938
| 11,589.3984
| 23
|
white
| 21.5
| 15
| 0.849976
| 0.797974
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 13
| 109
| 6
| 46
| 24
| 35.89844
| 313.3125
| 3.899902
| 0.299988
| 0.699951
| 141
| 7.379883
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,827
| 0
|
74.52698
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 20
|
$11-$25k
| 0
| 7,505
| 6,412.2891
| 4,423.34766
| 10.5
|
white
| 18.199219
| 38
| 0.816895
| 0.702881
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 13
| 59
| 10.199219
| 76
| 14
| 36.29688
| null | null | null | 1.5
| 134
| 7.589844
| null | null | null | 0
| 1
|
adl>=4 (>=5 if sur)
| 1
| 92
| 1
|
70.78699
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 3
| 8
| null | 0
| 3,736
| 2,807.2519
| 2,294.21875
| 18
|
white
| 21.199219
| 35
| 0.599976
| 0.281982
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
dnr after sadm
| 1
| 68
| 14.099609
| 69
| 32
| 36.29688
| null | null | null | 1.5
| 132
| null | null | null | null | null | 0
| null | 0
| 129
| 1
|
40.17798
|
male
| 0
| 25
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 18
| null | 0
| 14,033
| 12,213.4141
| 8,536.73438
| 9.75
|
white
| 25.199219
| 22
| 0.876953
| 0.795898
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 25
| 59
| 10
| 98
| 20
| 36.69531
| null | 2.799805
| 0.699951
| 1.199951
| 128
| null | null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,825
| 0
|
63.439
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| null | null | 0
| 10,268
| 8,213.5078
| 8,644.08594
| 6
|
white
| 32.59375
| 41
| 0.599976
| 0.41095
| 1
| 1
| 0
|
yes
| 0.5
| 0.2
|
dnr after sadm
| 3
| 66
| 12.798828
| 104
| 28
| 35.29688
| null | null | null | 1.899902
| 124
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.602539
| 15
| 1
|
56.99399
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 3,978
| 3,115.3379
| 2,650.6582
| 12
|
white
| 18.796875
| 34
| 0.904907
| 0.839966
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 2
| 59
| 17.898438
| 93
| 24
| 35.69531
| 284
| 4.199219
| 0.5
| 1.899902
| 135
| 7.419922
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,823
| 0
|
56.68399
|
male
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| 11
|
$25-$50k
| 0
| 7,076
| 5,450.5039
| 4,836.07812
| 9.5
|
white
| 24.898438
| 29
| 0.545898
| 0.222992
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 69
| 18.199219
| 122
| 26
| 38.59375
| 176.65625
| null | null | 0.799927
| 136
| 7.369141
| null | null | null | 2
| null |
<2 mo. follow-up
| 1.839
| 11
| 1
|
63.23099
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 2,849
| 2,504.1836
| 2,060.84961
| 5
|
white
| 13.398438
| 19
| 0.918945
| 0.863892
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 5
| 82
| 7.5
| 65
| 24
| 36.19531
| null | 3.899902
| 0.799927
| 1.299805
| 140
| null | null | null | null | null | null | null | 2.006836
| 1,250
| 1
|
51.49597
|
male
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 6
| 12
| null | 0
| 8,660
| 7,003.3945
| 5,817.53906
| 10.5
|
white
| 17.699219
| 32
| 0.824951
| 0.715942
| 1
| 0
| 0
|
yes
| 0.9
| 0.4
|
no dnr
| 8
| 68
| 8
| 79
| 15
| 36.29688
| null | 2.099609
| 3
| 1.099854
| 132
| null | null | null | null | 2
| 4
|
no(M2 and SIP pres)
| 4
| 69
| 1
|
75.422
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 0
| 18,862
| 13,873.7031
| 12,176.0391
| 24
|
white
| 26
| 47
| 0.680908
| 0.586914
| 6
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 12
| 53
| 15.5
| 78
| 20
| 38.19531
| 107.5
| null | null | 1.199951
| 139
| 7.459961
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 755
| 1
|
63.88797
|
male
| 0
| 9
|
Lung Cancer
|
Cancer
| 2
| 10
|
$11-$25k
| 0
| 4,809
| 3,962.3945
| 3,805.23828
| 7.5
|
white
| 15.099609
| 15
| 0.745972
| 0.483948
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 81
| null | 77
| 12
| 36.89844
| null | null | null | 1.199951
| 141
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 155
| 1
|
73.89996
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 23,842
| 16,305.4531
| 17,274.6094
| 32.333313
|
white
| 24.796875
| 49
| 0.746948
| 0.600952
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 14
| 78
| 12.599609
| 106
| 26
| 38.59375
| 80
| 2.899902
| 1.099854
| 1.199951
| 139
| 7.469727
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,818
| 0
|
73.19098
|
male
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 34,609
| 26,301.4688
| 23,111.4062
| 22
|
white
| 27.699219
| 30
| 0.553955
| 0.440979
| 14
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 103
| 16
| 82
| 36
| 39.19531
| 94.65625
| null | null | 0.599976
| 137
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 2.137695
| 5
| 1
|
71.37598
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 9
| 16,882
| 12,369.4453
| 12,698.8438
| 18
|
white
| 33.5
| 43
| 0.539917
| 0.34198
| 1
| 0
| 1
|
no
| 0.1
| 0.001
|
dnr after sadm
| 1
| 77
| 24.5
| 106
| 28
| 36.19531
| 288
| 2.899902
| 0.799927
| 4.699219
| 133
| 7.359375
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 285
| 1
|
60.931
|
male
| 1
| 4
|
Lung Cancer
|
Cancer
| 2
| null | null | 26
| 2,094
| 1,653.3262
| 1,407.85938
| 12
|
white
| 28.597656
| 41
| 0.289978
| 0.045998
| 1
| 1
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 56
| 18.898438
| 126
| 24
| 36.39844
| 319
| 3.199707
| 1.399902
| 1.299805
| 143
| 7.379883
| null | null | null | null | null |
<2 mo. follow-up
| 2.944824
| 4
| 1
|
58.75198
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 4
| 12
| null | 0
| 1,401
| 1,250.9248
| 1,065.85938
| 4
|
white
| 13.798828
| 18
| 0.777954
| 0.536987
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 65
| 6.5
| 114
| 20
| 36
| null | 4.099609
| 0.599976
| 1.099854
| 133
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 109
| 1
|
73.69196
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 8
|
$11-$25k
| 0
| 8,756
| 6,566.4023
| 6,206.01953
| 22
|
white
| 22.097656
| 43
| 0.684937
| 0.516968
| 7
| 0
| 0
|
yes
| 0.9
| 0.61
|
no dnr
| 5
| 69
| 16.597656
| 160
| 28
| 38.5
| 297.125
| 3.699707
| 0.199982
| 1
| 130
| 7.389648
| null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 30
| 1
|
67.68195
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 16
|
>$50k
| 0
| 2,699
| 2,069.0703
| 1,551.36914
| 9
|
white
| 14.599609
| 23
| 0.746948
| 0.485962
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 5
| 65
| 6.099609
| 101
| 24
| 35.79688
| null | 4
| 0.399963
| 0.899902
| 131
| null | null | null | null | 2
| null |
no(M2 and SIP pres)
| 1.839
| 500
| 1
|
66.57599
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
| null | 0
| 16,643
| 14,302.6328
| 12,509.9062
| 35
|
white
| 12.798828
| 16
| 0.917969
| 0.860962
| 1
| 1
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 11
| 72
| null | 68
| 24
| 36.39844
| 306.625
| 4
| 1.299805
| 0.899902
| 135
| 7.5
| null | null | null | 1
| 3
|
<2 mo. follow-up
| 3
| 17
| 1
|
57.46698
|
female
| 0
| 27
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 26,240
| 19,473.25
| 21,596.9531
| 13.25
|
white
| 18.097656
| 29
| 0.829956
| 0.7229
| 1
| 1
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 27
| 74
| 8.099609
| 87
| 20
| 36.69531
| 596.25
| 2.799805
| 1.899902
| 1.699951
| 134
| 7.369141
| null | null | null | 5
| 4
|
no(M2 and SIP pres)
| 4
| 122
| 1
|
57.75998
|
female
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 26
| 34,429
| 26,154.9844
| 23,527.6875
| 25.666656
|
white
| 26.296875
| 28
| 0.623901
| 0.519897
| 3
| 0
| 0
|
yes
| 0.7
| 0.6
|
no dnr
| 24
| 119
| 11.398438
| 150
| 28
| 36.39844
| 222.4375
| 3.399902
| 0.399963
| 0.599976
| 133
| 7.399414
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 743
| 1
|
82.56299
|
female
| 1
| 4
|
Coma
|
Coma
| 0
| null | null | 94
| 3,348
| 2,935.7285
| 2,534.5
| 18
|
white
| 23.296875
| 14
| 0.106995
| 0.064987
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 123
| 13.099609
| 59
| 24
| 39
| 114
| null | null | 0.899902
| 141
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 2.734863
| 4
| 1
|
61.27298
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 4
| 16
|
>$50k
| 0
| 2,824
| 2,126.25
| 1,740.51953
| 9
|
white
| 5.399414
| 12
| 0.87793
| 0.724976
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.4
|
no dnr
| 5
| 79
| 9.298828
| 83
| 20
| 36.89844
| null | 4.199219
| 0.199982
| 0.899902
| 137
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 503
| 1
|
46.44498
|
female
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 3,171
| 2,591.4394
| 2,048.11914
| 19
|
white
| 18.296875
| 23
| 0.872925
| 0.78894
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 5
| 83
| 7.599609
| 76
| 20
| 36.79688
| null | 2.399902
| 6
| 1.099854
| 136
| null | null | null | null | null | null | null | 2.130371
| 78
| 1
|
77.46698
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 10,748
| 8,356.8438
| 7,587.4375
| 9.333328
|
white
| 18.699219
| 45
| 0.836914
| 0.781982
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
dnr after sadm
| 1
| 67
| 11.599609
| 104
| 32
| 38.09375
| 285.6875
| 4.099609
| 0.899902
| 1
| 139
| 7.319336
| null | null | null | 2
| 4
|
no(M2 and SIP pres)
| 4
| 261
| 1
|
74.86694
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
|
under $11k
| 0
| 2,715
| 2,189.9961
| 1,840.59961
| 8
|
white
| 17.5
| 39
| 0.846924
| 0.747925
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 5
| 77
| 12.898438
| 71
| 32
| 36.39844
| 233.3125
| null | null | 0.899902
| 139
| 7.379883
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,802
| 0
|
78.297
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 3
|
under $11k
| 9
| 12,855
| 9,787.6484
| 8,389.22656
| 7.333332
|
white
| 22.199219
| 39
| 0.706909
| 0.61792
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 14
| 147
| 11.398438
| 110
| 42
| 36.79688
| 240
| 3.599609
| 0.399963
| 1.299805
| 140
| 7.399414
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,063
| 1
|
70.14099
|
male
| 1
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 100
| 17,808
| 14,600.1484
| 11,584.5078
| 44.5
|
white
| 37.398438
| 75
| 0.049995
| 0.004999
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 9
| 41
| 4.599609
| 122
| 44
| 39.69531
| 309.0625
| null | 0.699951
| 14
| 130
| 7.05957
| null | null | null | null | null |
<2 mo. follow-up
| 4.21875
| 13
| 1
|
81.19098
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 6,344
| 5,242.9648
| 4,108.64844
| 9.5
|
white
| 29.097656
| 50
| 0.639893
| 0.459961
| 1
| 0
| 0
|
no
| 0.6
| 0.4
|
dnr after sadm
| 1
| 51
| 33.695313
| 73
| 28
| 35
| 295.1875
| null | null | 1.299805
| 135
| 7.5
| null | null | null | 0
| null | null | 0.4948
| 99
| 1
|
68.69299
|
male
| 1
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 0
| 12
| null | 0
| 11,160
| 7,682.8633
| 8,087.65625
| 19
|
white
| 21.699219
| 29
| 0.704956
| 0.542969
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
dnr after sadm
| 6
| 103
| 12.099609
| 104
| 34
| 37.89844
| 250
| 2.5
| 1
| 1.699951
| 149
| 7.439453
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
72.35596
|
female
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
| null | 9
| 88,405
| 58,013.2188
| 54,539.2812
| 35.5
|
white
| 24.5
| 39
| 0.671997
| 0.576904
| 12
| 1
| 0
|
no
| 0.2
| 0.1
|
no dnr
| 32
| 60
| 26.699219
| 160
| 8
| 39.39844
| 191.09375
| 2.699707
| 0.699951
| 1.199951
| 148
| 7.459961
| null | null | null | null | 2
|
adl>=4 (>=5 if sur)
| 2
| 1,798
| 0
|
68.68396
|
male
| 1
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 9
| 4,790
| 3,761.4238
| 3,532.36914
| 7.5
|
white
| 30.5
| 52
| 0.35498
| 0.164978
| 1
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr before sadm
| -1
| 72
| 13.398438
| 110
| 26
| 36.5
| null | 2.199707
| 1.599854
| 6.199219
| 129
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
77.26794
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 1,990
| 1,382.8867
| 1,067.67969
| 11
|
white
| 16.796875
| 10
| 0.682983
| 0.387939
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.25
|
no dnr
| 3
| 81
| null | 76
| 20
| 35.79688
| null | null | null | 0.699951
| 140
| null | null | null | null | null | null | null | 2.374512
| 710
| 1
|
69.02399
|
male
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 5,258
| 4,392.2266
| 3,594.88867
| 9.5
|
white
| 21.796875
| 32
| 0.700928
| 0.537964
| 1
| 0
| 0
|
no
| 0.2
| 0.5
|
dnr after sadm
| 5
| 114
| 12.398438
| 106
| 24
| 38
| 414.25
| 2.699707
| 3.199707
| 1.699951
| 136
| 7.529297
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 15
| 1
|
63.39499
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 3,169
| 2,724.1191
| 2,163.16992
| 12
|
white
| 17.5
| 26
| 0.888916
| 0.814941
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 69
| 7.399414
| 76
| 24
| 36
| null | null | null | 1.5
| 134
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.84082
| 810
| 1
|
62.63898
|
male
| 0
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 18,106
| 12,157.1406
| 10,354.3359
| 16
|
white
| 17.097656
| 21
| 0.755981
| 0.677979
| 15
| 0
| 0
|
yes
| 0.6
| 0.5
|
no dnr
| 4
| 111
| 8.199219
| 65
| 24
| 35.79688
| 328
| null | null | 1.5
| 139
| 7.379883
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 735
| 1
|
75.75598
|
female
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
|
$11-$25k
| 0
| 9,652
| 8,003.9648
| 6,383.47656
| 10.666664
|
white
| 21.296875
| 39
| 0.765991
| 0.62793
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 14
| 65
| 15.599609
| 93
| 20
| 36.19531
| 206.65625
| 4.299805
| 0.799927
| 2.299805
| 130
| 7.489258
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,143
| 1
|
45.021
|
female
| 0
| 26
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 39,258
| 30,343.0781
| 28,235.6094
| 17.5
|
white
| 25.796875
| 36
| 0.787964
| 0.659912
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 26
| 65
| 19
| 130
| 12
| 36.19531
| 226
| 2.399902
| 4
| 1
| 147
| 7.439453
| null | null | null | 6
| null |
no(M2 and SIP pres)
| 4.527397
| 1,795
| 0
|
79.47198
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 4
|
under $11k
| 0
| 6,229
| 4,599.8047
| 3,860.43945
| 14.5
|
white
| 15.199219
| 20
| 0.814941
| 0.602905
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 1
| 68
| 7.799805
| 78
| 22
| 35.79688
| null | null | 0.399963
| 0.899902
| 138
| null | null | null | null | 5
| null |
no(M2 and SIP pres)
| 3.855299
| 228
| 1
|
82.91895
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null |
$25-$50k
| 0
| 6,971
| null | null | 12
|
white
| 25.898438
| 38
| 0.698975
| 0.535889
| 1
| 1
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 8
| 70
| 15.699219
| 102
| 12
| 36.59375
| 114
| 3.899902
| 0.699951
| 1.599854
| 139
| 7.369141
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 738
| 1
|
61.24298
|
male
| 0
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
$11-$25k
| 9
| 22,190
| 15,718.0469
| 14,078.2188
| 19.333328
|
white
| 27.699219
| 36
| 0.581909
| 0.471985
| 1
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 17
| 113
| 10.798828
| 46
| 24
| 35.69531
| null | 3.199707
| 0.399963
| 2.5
| 132
| null | null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,795
| 0
|
71.72095
|
male
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 9
| 13,773
| 9,978.6094
| 8,378.07812
| 18.5
|
white
| 7.299805
| 21
| 0.892944
| 0.755981
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 12
| 71
| 6.799805
| 60
| 20
| 35.59375
| null | 4.399414
| 0.599976
| 1.199951
| 140
| null | null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 757
| 1
|
54.366
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 4,439
| 3,419.9531
| 3,195.09961
| 4
|
white
| 7.799805
| 10
| 0.862915
| 0.692993
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.05
|
dnr after sadm
| 1
| 106
| 11.599609
| 73
| 20
| 36.19531
| null | 4.299805
| 0.399963
| 0.799927
| 135
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.467773
| 18
| 1
|
85.36896
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 9
| 5,435
| 3,947.9746
| 3,281.05859
| 20
|
white
| 23
| 50
| 0.715942
| 0.628906
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 3
| 67
| 8.099609
| 72
| 44
| 38.19531
| 134.28125
| 3.899902
| 1.399902
| 1.399902
| 153
| 7.269531
| null | null | null | null | null |
<2 mo. follow-up
| 2.605957
| 6
| 1
|
71.12897
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 6
|
under $11k
| 0
| 3,305
| 2,610.459
| 2,755.57812
| 13
|
white
| 19.898438
| 32
| 0.628906
| 0.317993
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 118
| null | 81
| 36
| 35.69531
| null | null | null | 1.599854
| 138
| null | null | null | null | null | null | null | 3.232422
| 396
| 1
|
43.12097
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 0
| 25,591
| 16,153.5859
| 18,159.7188
| 36.5
|
white
| 22.597656
| 43
| 0.866943
| 0.820923
| 3
| 0
| 0
|
no
| 0.4
| 0.5
|
no dnr
| 11
| 148
| 6
| 160
| 42
| 39
| 340
| 2.599609
| 0.399963
| 0.899902
| 144
| 7.40918
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 11
| 1
|
59.715
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 0
| 15,675
| 12,458.0078
| 10,295.7891
| 13
|
white
| 24.796875
| 34
| 0.768921
| 0.631958
| 11
| 1
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 11
| 101
| 13.5
| 96
| 20
| 36.29688
| 161.21875
| 3.899902
| 0.5
| 2.799805
| 136
| 7.399414
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 1,783
| 0
|
75.25299
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 5
| null | 0
| 1,982
| 1,703.4512
| 1,200.72949
| 15
|
white
| 16.699219
| 22
| 0.688965
| 0.396973
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 4
| 98
| 4.599609
| 79
| 24
| 35.09375
| null | 3.699707
| 0.699951
| 1.5
| 135
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.118652
| 1,224
| 1
|
81.85895
|
male
| 1
| 8
|
Coma
|
Coma
| 2
| null | null | 100
| 30,573
| 22,404.1562
| 20,921.7344
| 43
|
white
| 18.199219
| 29
| 0.074997
| 0.042
| 7
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 5
| 134
| 11.699219
| 120
| 10
| 38
| 266.625
| 3.099609
| 0.5
| 1.199951
| 140
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 3.027832
| 8
| 1
|
58.30499
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 4,919
| 3,350.6582
| 2,425.60938
| 10
|
white
| 6.599609
| 17
| 0.870972
| 0.709961
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 101
| 4.199219
| 76
| 22
| 35.89844
| null | 4.299805
| 0.699951
| 1.199951
| 136
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,777
| 0
|
66.99194
|
male
| 0
| 12
|
Coma
|
Coma
| 1
| null | null | 0
| 7,107
| 5,761.1719
| 5,130.54688
| 10
|
white
| 17.796875
| 22
| 0.67688
| 0.620972
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.05
|
dnr after sadm
| 1
| 101
| 12.099609
| 71
| 24
| 35.59375
| 261.875
| 3.699707
| 0.699951
| 0.899902
| 137
| 7.479492
| null | null | null | null | null | null | 2.308106
| 289
| 1
|
73.63397
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 11,955
| 9,600.3672
| 7,533.54688
| 9
|
white
| 27.597656
| 43
| 0.711914
| 0.623901
| 1
| 0
| 1
|
no
| 0.95
| 0.95
|
no dnr
| 19
| 66
| 25.296875
| 104
| 28
| 38.79688
| 142.84375
| 4
| 1
| 1.099854
| 130
| 7.519531
| null | null | null | null | null | null | 4.679688
| 1,018
| 1
|
68.45398
|
female
| 1
| 22
|
Coma
|
Coma
| 2
| null | null | 55
| 31,886
| 27,470.5625
| 22,788.8281
| 24.666656
|
white
| 23.398438
| 39
| 0.371948
| 0.29895
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 50
| 5.399414
| 72
| 10
| 37.89844
| 330
| 2.699707
| 2.399902
| 1.899902
| 137
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 2.250488
| 22
| 1
|
79.04395
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 0
| 14,976
| 11,266.9609
| 8,886.63281
| 7.333332
|
white
| 19.898438
| 30
| 0.794922
| 0.726929
| 3
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 15
| 103
| 16.199219
| 104
| 28
| 38.59375
| null | null | null | 1.299805
| 136
| null | null | null | null | 1
| 1
| null | 1
| 1,184
| 1
|
84.89795
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
under $11k
| 0
| 58,625
| 39,888.9688
| 40,975.3125
| 30
|
white
| 31.398438
| 41
| 0.445984
| 0.326965
| 20
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr before sadm
| -13
| 70
| 21.296875
| 130
| 10
| 35.79688
| 113.32812
| 3.199707
| 1.299805
| 1.399902
| 140
| 7.469727
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 24
| 1
|
71.685
|
male
| 0
| 62
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 157,606
| 118,813.875
| 98,656.1875
| 34.5
|
white
| 26.097656
| 44
| 0.67395
| 0.578979
| 13
| 0
| 0
|
no
| 0.6
| 0.58
|
no dnr
| 62
| 56
| 22.597656
| 122
| 10
| 38.69531
| 262.5
| 3
| 2.199707
| 1.599854
| 145
| 7.459961
| null | null | null | null | null | null | 2.273926
| 1,771
| 0
|
64.24597
|
female
| 0
| 10
|
Lung Cancer
|
Cancer
| 3
| 12
|
under $11k
| 0
| 6,996
| 5,719.0234
| 7,208.16797
| 11.5
|
white
| 20.699219
| 29
| 0.630981
| 0.31897
| 1
| 1
| 0
|
metastatic
| 0.6
| 0.5
|
no dnr
| 10
| 70
| 6.399414
| 130
| 28
| 38.59375
| null | 3.599609
| 0.299988
| 0.699951
| 132
| null | null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 117
| 1
|
59.26099
|
male
| 0
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
>$50k
| 0
| 2,339
| 1,853.75
| 1,908.63965
| 19
|
white
| 23.097656
| 33
| 0.836914
| 0.781982
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 55
| 7.799805
| 76
| 20
| 36.09375
| null | 4.199219
| 1.599854
| 1.5
| 129
| null | null | null | null | 6
| null |
no(M2 and SIP pres)
| 4.527397
| 107
| 1
|
70.43695
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 4
| null | 0
| 4,158
| 3,417.3438
| 2,814.97852
| 10
|
white
| 14.599609
| 15
| 0.896973
| 0.827881
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 7
| 82
| 8.298828
| 63
| 24
| 35.89844
| 385.6875
| 4.099609
| 0.699951
| 1.199951
| 132
| 7.429688
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,769
| 0
|
74.85596
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 26
| 11,499
| 7,894.8828
| 5,474.85938
| 8
|
white
| 33.296875
| 62
| 0.448975
| 0.328979
| 1
| 0
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 1
| 73
| 0.899902
| 82
| 28
| 36.19531
| 347.5625
| 2.899902
| 6.5
| 1.699951
| 133
| 7.429688
| null | null | null | 4
| 7
|
<2 mo. follow-up
| 7
| 17
| 1
|
51.23099
|
female
| 1
| 94
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 144,148
| 137,408.625
| 134,868.375
| 35.5
|
white
| 32.796875
| 68
| 0.553955
| 0.440979
| 16
| 0
| 0
|
yes
| 0.6
| 0.6
|
dnr after sadm
| 92
| 149
| 7.299805
| 112
| 40
| 38.89844
| 110
| 2.299805
| 1
| 2.599609
| 148
| 7.429688
| null | null | null | null | 4
| null | 4
| 94
| 1
|
78.57397
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
| null | 0
| 6,569
| 5,492.7266
| 6,386.76953
| 15
|
white
| 26.199219
| 49
| 0.679932
| 0.509888
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 10
| 109
| 7
| 120
| 32
| 36
| 280.9375
| 4
| 0.299988
| 2.899902
| 131
| 7.359375
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,524
| 1
|
42.88599
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 2,807
| 2,326.2715
| 1,821.81934
| 11
|
white
| 1.5
| 21
| 0.955933
| 0.894897
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 62
| 2.399902
| 81
| 16
| 36.39844
| null | 4.699219
| 0.399963
| 0.899902
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 240
| 1
|
58.19299
|
male
| 0
| 17
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 15,429
| 11,362.0781
| 9,369.60938
| 13.666664
|
white
| 6.899414
| 31
| 0.920898
| 0.814941
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 12
| 104
| 6.899414
| 110
| 24
| 37.59375
| null | 4.699219
| 0.599976
| 1.299805
| 131
| null | null | null | null | null | null |
<2 mo. follow-up
| 1.877441
| 49
| 1
|
66.47998
|
female
| 0
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
| null | 0
| 39,037
| 26,767.1094
| 23,013.8594
| 19.333328
|
white
| 30.597656
| 35
| 0.429993
| 0.310974
| 13
| 0
| 0
|
yes
| 0.5
| 0.25
|
no dnr
| 21
| 103
| 0.399963
| 118
| 24
| 36.69531
| null | 2.5
| 1.199951
| 0.799927
| 131
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,762
| 0
|
69.08398
|
male
| 0
| 36
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null | null | 9
| 61,341
| 39,997.9062
| 45,110.875
| 38.75
|
white
| 25.796875
| 25
| 0.678955
| 0.508911
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 29
| 70
| 18
| 112
| 9
| 36.09375
| 256
| 2.799805
| 1.299805
| 1.099854
| 143
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 3.189453
| 38
| 1
|
82.05298
|
female
| 0
| 27
|
Coma
|
Coma
| 3
| 10
|
under $11k
| 44
| 31,768
| 22,055.1719
| 25,770.9688
| 25.5
|
white
| 25.097656
| 38
| 0.284973
| 0.214996
| 1
| 0
| 1
|
no
| 0.3
| 0.1
|
no dnr
| 27
| 74
| 12.699219
| 120
| 36
| 39.69531
| 187.09375
| 3.299805
| 0.799927
| 1.199951
| 137
| 7.439453
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 144
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.